M. Colin et al., ALTERATIONS OF VINBLASINE INFLUX IN MULTIDRUG-RESISTANT LYMPHOBLASTICLEUKEMIC CEM CELLS, Anticancer research, 16(1), 1996, pp. 407-412
Typical mutlidrug-resistant (MDR) CEM/VLB(100) cells exhibited reduced
uptake of vinblastine (VLB) compared to their sensitive CEM counterpa
rts, mean results were respectively, 3.19 and 35.4 pmol per 10(6) cell
s. In CEM cells, the efflux of drug reached a steady state after 10-15
min while in CEM/VLB(100) cells, the typical P170-mediated efflux was
still efficient after 40 min. Nevertheless, the most striking differe
nce observed in CEM/VLB(100) cells was a dramatic decrease in early (3
0 sec) influx of drug which was 10 times lover than in sensitive cells
, a characteristic still observed in the presence of Na azide and abse
nce of glucose. MDR modulators increased influx in MDR cells without l
ittle or no effect on sensitive cells. The Q(10) entry of VLB into sen
sitive cells was 1.2 while it was 2.2 in CEM, suggesting that the mode
of entry of VLB into MDR cells differed from that of CEM cells. Verap
amil or nigericin, which rapidly increased the accumulation of VLB rai
sed the Q(10) to >2. These results suggest that the primary defect in
MDR cells would be an inhibition of influx, which might involve intera
ctions with P170 through a reversible process.